Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | STAT3 | P40763 | 1/20 | 0.46 |
| ▸ | STAT1 | P42224 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | PTGES | O14684 | 1/20 | 0.45 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16015328 | 0.88 | MAPT (0.57) | SMN1; SMN2ALDH1A1MAPTKDM4EHDAC6 | |
| SCHEMBL16015335 | 0.87 | LMNA (0.61) | SMN1; SMN2MAPTKDM4EHDAC6LMNA | |
| SCHEMBL7237622 | 0.81 | ALDH1A1 (0.63) | SMN1; SMN2ALDH1A1MAPTKDM4EHDAC6 | |
| SCHEMBL262288 | 0.81 | MAPT (0.56) | SMN1; SMN2ALDH1A1MAPTKDM4EHDAC6 | |
| SCHEMBL23067512 | 0.79 | KDM4E (0.66) | SMN1; SMN2ALDH1A1MAPTKDM4EHDAC6 | |
| SCHEMBL16015337 | 0.79 | PTGES (0.53) | ALDH1A1MAPTKDM4ELMNAMEN1 | |
| SCHEMBL16253498 | 0.79 | LMNA (0.49) | SMN1; SMN2MAPTKDM4ELMNANPC1 | |
| SCHEMBL6365561 | 0.79 | SMN1; SMN2 (0.52) | SMN1; SMN2ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL18027718 | 0.77 | MEN1 (0.60) | SMN1; SMN2MAPTKDM4EMEN1NPC1 | |
| SCHEMBL12563268 | 0.77 | RXRA (0.60) | MAPTMEN1KMT2AFFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9201001-B2 | Visual detection of fluoride ions | INDIAN INSTITUTE OF TECHNOLOGY MADRAS (IN) | 2015-12-01 | — | — | US | disclosed |
| US-20140357894-A1 | VISUAL DETECTION OF FLUORIDE IONS | EMPIRE TECHNOLOGY DEVELOPMENT LLC | 2014-12-04 | — | — | US | disclosed |
| US-8828735-B2 | Visual detection of fluoride ions | INDIAN INSTITUTE OF TECHNOLOGY MADRAS (IN) | 2014-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140357894-A1 | VISUAL DETECTION OF FLUORIDE IONS | HNRNPL, HNRNPLL, ARAF | SMN1; SMN2 3901/4885ALDH1A1 1801/4885MAPT 1641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.